Undervalued Stocks Based On Cash Flows

Results

146

34 new

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

146 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
GSHD
New
US$68.394.3%-22.7%US$2.3bUS$68.9246.120.4%0%Insurance
OCFC
New
US$19.220.4%10.9%US$1.9bUS$22.080.865.1%4.2%Banks
CPRI
US$14.40-7.4%-28.5%US$1.6bUS$22.5317.824.4%n/aConsumer Durables
ALRS
US$32.68-3.4%51.3%US$836.7mUS$35.4029.540.6%2.7%Diversified Financials
HBAN
US$17.17-3.9%2.2%US$35.7bUS$20.301.225.7%3.6%Banks
TYGO
New
US$1.14-6.6%-11.6%US$88.3mUS$2.838.823.1%n/aCapital Goods
SPT
New
US$10.035.0%-31.4%US$594.4mUS$10.441.3107.1%n/aSoftware
WLTH
US$9.08-3.1%n/aUS$1.3bUS$12.253.785.4%n/aDiversified Financials
CBRS
New
US$215.69-17.7%n/aUS$52.3bUS$291.6475.3116.8%n/aSemiconductors
MWH
New
US$29.97-0.4%n/aUS$6.1bUS$45.1831.121.4%n/aCapital Goods
SYM
US$42.022.0%-5.6%US$24.5bUS$64.32664.855.5%n/aCapital Goods
GLOO
US$3.33-2.3%n/aUS$266.9mUS$12.332.2105.5%n/aSoftware
J
US$147.371.4%0.6%US$16.7bUS$162.5348.028.7%1.0%Commercial Services
NTRA
New
US$325.072.9%102.4%US$44.9bUS$336.7417.362.6%n/aPharmaceuticals & Biotech
HTB
New
US$47.10-5.4%18.9%US$786.7mUS$54.751.325.6%1.3%Banks
YOU
US$44.30-4.0%31.9%US$6.0bUS$62.6030.822.0%1.8%Software
ZETA
US$28.790.8%58.4%US$7.1bUS$31.364.649.1%n/aSoftware
MELI
US$1,908.654.4%-18.3%US$90.2bUS$2,256.5451.929.0%0%Retail
GPC
US$134.540.4%-1.8%US$18.2bUS$140.38566.141.7%3.2%Retail
XERS
New
US$8.783.4%16.0%US$1.6bUS$11.294.855.9%n/aPharmaceuticals & Biotech
RHI
US$43.544.8%18.7%US$4.4bUS$35.0038.231.8%5.4%Commercial Services
COHR
New
US$287.47-19.2%232.1%US$60.0bUS$416.0973.143.9%n/aTech
FORM
US$114.95-10.7%312.0%US$9.7bUS$138.6377.843.7%n/aSemiconductors
MBLY
US$9.103.4%-34.3%US$7.5bUS$12.113.894.2%n/aAutomobiles
Page 1 of 5